| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0009400 | Intron-Exon-Intron | chr16:68181411-68217269 | chr16:68147508-68183366 | 183 nt | 0.4481 |
| hsa_chr16_0275800 | Intergenic-Intergenic | chr16:68182164-68182665 | chr16:68148261-68148762 | 502 nt | 0.3566 |
| hsa_NFATC3_0009500 | Intron-Intron | chr16:68186562-68187191 | chr16:68152659-68153288 | 630 nt | 0.4063 |
| hsa_NFATC3_0010000 | Exon-Exon | chr16:68191772-68215433 | chr16:68157869-68181530 | 56 nt | 0.4821 |
| hsa_NFATC3_0009900 | Exon-Exon | chr16:68191772-68225510 | chr16:68157869-68191607 | 1537 nt | 0.4379 |
| hsa_NFATC3_0010100 | Exon-Exon | chr16:68191772-68225678 | chr16:68157869-68191775 | 206 nt | 0.4029 |
| hsa_NFATC3_0010200 | Exon-Exon | chr16:68191772-68248335 | chr16:68157869-68214432 | 200 nt | 0.4050 |
| hsa_NFATC3_0010400 | Exon-Exon | chr16:68191862-68200918 | chr16:68157959-68167015 | 283 nt | 0.4170 |
| hsa_NFATC3_0010500 | Exon-Exon | chr16:68191862-68208417 | chr16:68157959-68174514 | 424 nt | 0.4057 |
| hsa_NFATC3_0010600 | Exon-Exon | chr16:68191862-68248335 | chr16:68157959-68214432 | 1719 nt | 0.4468 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].